Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.071 | 0.02 |
mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |